查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1589334

心臟去顫器市場：按類型、最終用戶、患者類型分類 - 2025-2030 年全球預測

Defibrillators Market by Type (External Defibrillators, Implantable Cardioverter Defibrillators), End-User (Alternate Care Facilities, Home Care Settings, Hospitals, Clinics, & Cardiac Centers), Patient Type - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年心臟去顫器市場規模為140.7億美元，預計2024年將達到149.6億美元，複合年成長率為6.77%，到2030年將達到222.7億美元。

心臟去顫器市場包括各種用於透過向心臟發送電脈衝或電擊來恢復正常心率的醫療設備。這些設備對於治療危及生命的心律不整、心室顫動和無脈性心室心搏過速至關重要。這項需求主要源於全球心血管疾病的增加和心臟麻痹的盛行率不斷增加，這使得它在緊急應變以及公共場所、醫院和家庭中變得至關重要。心臟去顫器有多種形式，包括自動體外心臟去顫器(AED)、置入式除顫器和穿戴式心臟去顫器，服務於各種最終用戶，包括醫院、院前、救護車和家庭。

主要市場統計
基準年[2023] 140.7億美元
預測年份 [2024] 149.6億美元
預測年份 [2030] 222.7億美元
複合年成長率（%） 6.77%

市場成長受到技術進步、人口老化、社會意識提高以及促進AED部署的有利政府政策等因素的影響。除顫心臟去顫器普及率低、人工智慧和機器學習的進步可實現更好的預測分析，以及可攜式和心臟去顫器心臟去顫器的新興趨勢，新興市場充滿了機會。抓住這些機會的建議包括透過研發擴大產品範圍，特別是在穿戴式技術方面，以及在開拓地區建立策略夥伴關係。

然而，高昂的設備成本、嚴格的監管核准流程以及低度開發地區缺乏認知均是成長面臨的挑戰。創新機會在於開發具有成本效益的模型、增強即時監控的連接性以及將心臟去顫器與遠端醫療平台整合以提高可訪問性和響應時間。隨著向使用者友善智慧型裝置的轉變，市場的性質不斷發展，為醫療專業人員和公眾提供支援。總之，心臟去顫器市場是醫療設備產業的一個充滿活力的重要組成部分，不斷創新以滿足全球不斷成長的醫療需求，並專注於降低成本和改進技術整合，改善患者的整體治療效果。

市場動態：快速發展的心臟去顫器市場的關鍵市場洞察

心臟去顫器市場正因供需的動態交互作用而轉變。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 心臟病快速增加
    • 增加公共場所心臟去顫器的可用性以及相關培訓和意識提升計劃
    • 有利於增加心臟去顫器採用的支援法規
  • 市場限制因素
    • 對植入式和自動體外心臟去顫器應用的擔憂
  • 市場機會
    • S-ICD、MRI 相容和 CRT-D 的開發正在進行中
    • 院前救護環境對自動體外心臟去顫器的需求不斷成長
  • 市場挑戰
    • 故障和頻繁的產品召回

波特五力：駕馭心臟去顫器市場的戰略工具

波特的五力框架是了解心臟去顫器市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解心臟去顫器市場的外部影響

外部宏觀環境因素在塑造心臟去顫器市場的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解心臟去顫器市場的競爭格局

心臟去顫器市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位心臟去顫器市場供應商的績效評估

FPNV定位矩陣是評估心臟去顫器市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議，描繪心臟去顫器市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，心臟去顫器市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 心臟病發生率迅速增加
      • 增加公共場所心臟去顫器的可用性以及培訓和意識提升計劃
      • 擴大除顫心臟去顫器採用的有利支援法規
    • 抑制因素
      • 對植入式和自動外部系統心臟去顫器應用的擔憂
    • 機會
      • S-ICD、MRI 相容、CRT-D 開發正在進行中
      • 院前環境對自動體外心臟去顫器的需求不斷成長
    • 任務
      • 故障和頻繁的產品召回
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章心臟去顫器市集：依類型

  • 體外去顫心臟去顫器
  • 植入式心臟整流去顫器心臟去顫器
    • 皮下植入式心臟整流去顫器心臟去顫器
    • 經靜脈皮下植入式心臟整流去顫器心臟去顫器
      • 雙心室 ICD/心臟再同步治療心臟去顫器
      • 雙腔室ICD
      • 單腔ICD

第7章心臟去顫器市場：依最終用戶分類

  • 替代性照顧設施
  • 家庭護理設置
  • 醫院、診所、心臟中心
  • 院前急救現場

第 8 章依病患類型心臟去顫器市場

  • 成人用
  • 小兒科

第9章 北美和南美心臟去顫器市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太除顫心臟去顫器市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲心臟去顫器市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • AMI Italia Srl
  • Axion Ltd.
  • Baxter International Inc.
  • Bexen Cardio By Osatu S Coop
  • Biotronik SE & CoKG
  • Boston Scientific Corporation
  • CU Medical Systems, Inc.
  • GE Healthcare
  • Koninklijke Philips NV
  • LivaNova PLC
  • Mediana Co., Ltd.
  • Medtonic PLC
  • Metsis Medikal
  • MicroPort Scientific Corporation
  • Narang Medical Limited
  • Nihon Kohden Corporation
  • Olympus Corporation
  • Progetti Srl
  • Schiller AG
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Stryker Corporation
  • Thermo Fisher Scientific Inc.
  • ZOLL Medical Corporation
Product Code: MRR-8A35583B11E2

The Defibrillators Market was valued at USD 14.07 billion in 2023, expected to reach USD 14.96 billion in 2024, and is projected to grow at a CAGR of 6.77%, to USD 22.27 billion by 2030.

The defibrillator market encompasses a range of medical devices used to restore a normal heartbeat by sending an electric pulse or shock to the heart. These devices are crucial in treating life-threatening cardiac dysrhythmias, ventricular fibrillation, and pulseless ventricular tachycardia. Necessity arises primarily from the global rise in cardiovascular diseases and the increasing prevalence of sudden cardiac arrests, making them vital in emergency responses and public spaces, hospitals, and homes. The application scope extends across various forms of defibrillators, including Automated External Defibrillators (AEDs), implanted defibrillators, and wearable defibrillators, catering to different end users such as hospitals, pre-hospital settings, ambulances, and households.

KEY MARKET STATISTICS
Base Year [2023] USD 14.07 billion
Estimated Year [2024] USD 14.96 billion
Forecast Year [2030] USD 22.27 billion
CAGR (%) 6.77%

Market growth is influenced by factors like technological advancements, the aging population, increased public awareness, and favorable governmental policies promoting AED deployment. Opportunities abound in emerging markets with low defibrillator penetration, advancements in AI and machine learning for better predictive analytics, and emerging trends in portable and wearable defibrillator technologies. Recommendations to capture these opportunities include expanding product offerings through R&D, especially in wearable technologies, and strategic partnerships for distribution in untapped regions.

However, growth is challenged by high device costs, stringent regulatory approval processes, and lack of awareness in underdeveloped regions. Innovative opportunities lie in developing cost-effective models, enhancing connectivity for real-time monitoring, and integrating defibrillators with telehealth platforms to improve accessibility and response times. The market's nature continues to evolve with a shift towards user-friendly, smart devices that empower both medical professionals and laypersons. In essence, the defibrillator market is a dynamic and essential component of the medical devices industry, constantly innovating to meet the growing health needs globally, with a focus on reducing costs and improving technological integration to enhance overall patient outcomes.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Defibrillators Market

The Defibrillators Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Surging incidences of cardiac disorders
    • Rising availability of defibrillators in public places coupled with training and awareness programs
    • Favorable supportive regulations for increased adoption of defibrillators
  • Market Restraints
    • Concerns pertinent to application of implantable and automated external defibrillators
  • Market Opportunities
    • Ongoing development of S-ICDs and MRI-compatible and CRT-Ds
    • Emerging demand for automated external defibrillators in prehospital environment
  • Market Challenges
    • Failure or frequent product recalls

Porter's Five Forces: A Strategic Tool for Navigating the Defibrillators Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Defibrillators Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Defibrillators Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Defibrillators Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Defibrillators Market

A detailed market share analysis in the Defibrillators Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Defibrillators Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Defibrillators Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Defibrillators Market

A strategic analysis of the Defibrillators Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Defibrillators Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AMI Italia S.r.l., Axion Ltd., Baxter International Inc., Bexen Cardio By Osatu S Coop, Biotronik SE & CoKG, Boston Scientific Corporation, CU Medical Systems, Inc., GE Healthcare, Koninklijke Philips N.V., LivaNova PLC, Mediana Co., Ltd., Medtonic PLC, Metsis Medikal, MicroPort Scientific Corporation, Narang Medical Limited, Nihon Kohden Corporation, Olympus Corporation, Progetti Srl, Schiller AG, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Stryker Corporation, Thermo Fisher Scientific Inc., and ZOLL Medical Corporation.

Market Segmentation & Coverage

This research report categorizes the Defibrillators Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across External Defibrillators and Implantable Cardioverter Defibrillators. The Implantable Cardioverter Defibrillators is further studied across Subcutaneous Implantable Cardioverter Defibrillators and TransvenoSubcutaneous Implantable Cardioverter Defibrillators. The TransvenoSubcutaneous Implantable Cardioverter Defibrillators is further studied across Biventricular ICDs/Cardiac Resynchronization Therapy Defibrillators, Dual-Chamber ICDs, and Single-Chamber ICDs.
  • Based on End-User, market is studied across Alternate Care Facilities, Home Care Settings, Hospitals, Clinics, & Cardiac Centers, and Prehospital Care Settings.
  • Based on Patient Type, market is studied across Adult and Pediatric.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Surging incidences of cardiac disorders
      • 5.1.1.2. Rising availability of defibrillators in public places coupled with training and awareness programs
      • 5.1.1.3. Favorable supportive regulations for increased adoption of defibrillators
    • 5.1.2. Restraints
      • 5.1.2.1. Concerns pertinent to application of implantable and automated external defibrillators
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing development of S-ICDs and MRI-compatible and CRT-Ds
      • 5.1.3.2. Emerging demand for automated external defibrillators in prehospital environment
    • 5.1.4. Challenges
      • 5.1.4.1. Failure or frequent product recalls
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Defibrillators Market, by Type

  • 6.1. Introduction
  • 6.2. External Defibrillators
  • 6.3. Implantable Cardioverter Defibrillators
    • 6.3.1. Subcutaneous Implantable Cardioverter Defibrillators
    • 6.3.2. TransvenoSubcutaneous Implantable Cardioverter Defibrillators
      • 6.3.2.1. Biventricular ICDs/Cardiac Resynchronization Therapy Defibrillators
      • 6.3.2.2. Dual-Chamber ICDs
      • 6.3.2.3. Single-Chamber ICDs

7. Defibrillators Market, by End-User

  • 7.1. Introduction
  • 7.2. Alternate Care Facilities
  • 7.3. Home Care Settings
  • 7.4. Hospitals, Clinics, & Cardiac Centers
  • 7.5. Prehospital Care Settings

8. Defibrillators Market, by Patient Type

  • 8.1. Introduction
  • 8.2. Adult
  • 8.3. Pediatric

9. Americas Defibrillators Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Defibrillators Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Defibrillators Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. AMI Italia S.r.l.
  • 3. Axion Ltd.
  • 4. Baxter International Inc.
  • 5. Bexen Cardio By Osatu S Coop
  • 6. Biotronik SE & CoKG
  • 7. Boston Scientific Corporation
  • 8. CU Medical Systems, Inc.
  • 9. GE Healthcare
  • 10. Koninklijke Philips N.V.
  • 11. LivaNova PLC
  • 12. Mediana Co., Ltd.
  • 13. Medtonic PLC
  • 14. Metsis Medikal
  • 15. MicroPort Scientific Corporation
  • 16. Narang Medical Limited
  • 17. Nihon Kohden Corporation
  • 18. Olympus Corporation
  • 19. Progetti Srl
  • 20. Schiller AG
  • 21. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • 22. Stryker Corporation
  • 23. Thermo Fisher Scientific Inc.
  • 24. ZOLL Medical Corporation

LIST OF FIGURES

  • FIGURE 1. DEFIBRILLATORS MARKET RESEARCH PROCESS
  • FIGURE 2. DEFIBRILLATORS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DEFIBRILLATORS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DEFIBRILLATORS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL DEFIBRILLATORS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL DEFIBRILLATORS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL DEFIBRILLATORS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL DEFIBRILLATORS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES DEFIBRILLATORS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES DEFIBRILLATORS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. DEFIBRILLATORS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. DEFIBRILLATORS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DEFIBRILLATORS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DEFIBRILLATORS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DEFIBRILLATORS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. DEFIBRILLATORS MARKET DYNAMICS
  • TABLE 7. GLOBAL DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL DEFIBRILLATORS MARKET SIZE, BY EXTERNAL DEFIBRILLATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL DEFIBRILLATORS MARKET SIZE, BY SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL DEFIBRILLATORS MARKET SIZE, BY BIVENTRICULAR ICDS/CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL DEFIBRILLATORS MARKET SIZE, BY DUAL-CHAMBER ICDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL DEFIBRILLATORS MARKET SIZE, BY SINGLE-CHAMBER ICDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL DEFIBRILLATORS MARKET SIZE, BY ALTERNATE CARE FACILITIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL DEFIBRILLATORS MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL DEFIBRILLATORS MARKET SIZE, BY HOSPITALS, CLINICS, & CARDIAC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL DEFIBRILLATORS MARKET SIZE, BY PREHOSPITAL CARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL DEFIBRILLATORS MARKET SIZE, BY ADULT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL DEFIBRILLATORS MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES DEFIBRILLATORS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 63. AUSTRALIA DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. CHINA DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. INDIA DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. INDONESIA DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. JAPAN DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. MALAYSIA DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. PHILIPPINES DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. PHILIPPINES DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. SINGAPORE DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. SINGAPORE DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. SOUTH KOREA DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. SOUTH KOREA DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. TAIWAN DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. TAIWAN DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. THAILAND DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. THAILAND DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. VIETNAM DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. VIETNAM DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 129. DENMARK DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. DENMARK DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. EGYPT DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. EGYPT DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. FINLAND DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. FINLAND DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. FRANCE DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. FRANCE DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. GERMANY DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. GERMANY DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. ISRAEL DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. ISRAEL DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. ITALY DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. ITALY DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. NETHERLANDS DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. NETHERLANDS DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. NIGERIA DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. NIGERIA DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. NORWAY DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. NORWAY DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. POLAND DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. POLAND DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. QATAR DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. QATAR DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. RUSSIA DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. RUSSIA DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 194. SAUDI ARABIA DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. SAUDI ARABIA DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 199. SOUTH AFRICA DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH AFRICA DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 204. SPAIN DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 205. SPAIN DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 209. SWEDEN DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 210. SWEDEN DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 214. SWITZERLAND DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 215. SWITZERLAND DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 219. TURKEY DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 220. TURKEY DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 224. UNITED ARAB EMIRATES DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. UNITED ARAB EMIRATES DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED KINGDOM DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED KINGDOM DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 234. DEFIBRILLATORS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 235. DEFIBRILLATORS MARKET, FPNV POSITIONING MATRIX, 2023